Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @kinapseglobal
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @kinapseglobal
-
Kinapse provides competitive
#Chemistry,#Manufacturing and#Control capabilities and our experts look forward to sharing their insights and experience with you. Are you interested in learning more? Contact us at info@kinapse.com#kinapse#regulatory#pharmaceuticalspic.twitter.com/KYLINHYRhi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kinapse, a Syneos Health company attends
#CBIConference, (January 22-24, Coral Gables, Florida). Join Kinapse's speakers and do not lose the opportunity to engage in a conversation with them.https://buff.ly/38glDn8Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Do ancillary document requests give you a headache? Follow the link to complete Kinapse's
#survey and help us understand your needs. https://buff.ly/378LRIk#regulatory#ancillary#requestspic.twitter.com/OdsN12bnsI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kinapse, a Syneos Health company will attend CBI
#Conference,#ClinicalData#Disclosure,#Transparency &#PlainLanguage Summaries on January 22-24, Coral Gables, Florida. https://buff.ly/38glDn8 Join Shalini Dwivedi at Session 7 and learn more about#HealthCanada PRCI.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kinapse welcomes the New Year by introducing its
#Regulatory capabilities. Do not hesitate to contact us and engage the conversation about your regulatory projects. info@kinapse.com#regulatorycompliance#strategy#clinical#regulatoryrequirementspic.twitter.com/giSlgpfPvY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On 4th Dec, ICH published final Q12
#guideline and its Annexes. Kinapse have the expertise to support and guide you in 2020!#pharma#ich#regulatoryrequirements Check our blog to learn more:https://buff.ly/35wAMzRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Reminder: Reserve now your place at our today’s
#Webinar and learn more about how to write high-quality Plain Language summaries. December 06 9 am EST | 2pm GMT | 3pm CET | Follow the link and register today: https://kinapse.com/PlainLanguageSummaries …#clinicaltrials#plainlanguagepic.twitter.com/8ZnhZj4k4z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kinapse wishes Happy
#Thanksgiving to all of our US colleagues, friends and their families!pic.twitter.com/vgqNOdI9uV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kinapse, a Syneos Health company will attend DIA CTD & Clinical Transparency conference, on December 04-05, 2019, in Amsterdam. Do not hesitate to meet our colleagues and engage the conversation about your project and disclosure requirements.
#syneoshealth#transparencyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kinapse would like to congratulate all the winners at the TOPRA awards last night celebrating regulatory achievement. We were pleased to be part of the celebrations with the Syneos Health global regulatory consulting team.
#syneoshealth#kinapse#TOPRA#Regulatorypic.twitter.com/F1Ot8SucB5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kinapse launches http://ClinTrialDataShare.com , a web portal for sponsors to publicly share plain language summaries of clinical trials. With the launch of this web portal, Kinapse is now able to provide end-to-end writing through dissemination services for PLS. https://buff.ly/33Xn6x0 pic.twitter.com/smSkHH3vGn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kinapse, a Syneos Health™ company is pleased to have submitted some suggestions and recommendations on the proposed United States Pharmacopeia’s (USP) policy changes related to reporting thresholds in USP-NF Monographs. Proposed Policy: https://buff.ly/32X41dd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Risk-Based Monitoring fulfils regulatory requirements for clinical trials sponsors and brings benefits to Biopharma companies when implemented. Follow the link and review Kinapse's recommendations for designing and implementing a successful RBM program.https://buff.ly/2KmixEL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Innovation brings a lot of advantages and opportunities for pharmaceutical businesses to face challenges, such as access to expertise. Follow the link below and review our suggestions based on experience https://buff.ly/2Pb0K6A pic.twitter.com/9porB4Cn5M
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
John Cogan held an excellent panel discussion on 'The future of regulatory affairs and the RA professional' on day 2 of TOPRA symposium. Follow the link below to read more: https://buff.ly/2pyAp7I pic.twitter.com/y8PjOy9Fym
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stuart Goodall and Angela Stokes attended the brilliant first day at TOPRA symposium yesterday. Big thank you to everyone who took out time and met us at booth # 13 for great conversation. We are excited for Day 2!
#booth13#TOPRASymposium2019#SymposiumDublin2019#TOPRASYM2019pic.twitter.com/mux5PRYzLb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stuart Goodall, Head of Regulatory Affairs is all set to attend TOPRA symposium, Dublin next week. Find Kinapse at Booth 13, we hope to see you there!
#booth13#TOPRASymposium2019#SymposiumDublin2019#TOPRASYM2019Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It's not too late to sign up to our webinar concerning Health Canada. Follow the link below to sign up today: https://buff.ly/2ZheIp0
#HealthCanada#Regulatory#Biostatisticspic.twitter.com/nhTwZZEVs4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2 of the Kinapse family will be speaking at the upcoming Veeva Summit in Philadelphia. Join Aatif Mehraj and Caroline Masterman-Smith from 3:45-4:30pm ET on September 9th as they discuss the future of RIM.
#Veeva#LifeSciences#RandDpic.twitter.com/XbyxGBLf7z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.